SCROLL
Xeureka Inc. uses the latest computational technology,
including cutting-edge AI and simulations,
to improve the efficiency and success rate of drug discovery research.
Ultimately, we aim to contribute to the swift,
economical delivery of effective medicines to patients suffering from disease.
TECHNOLOGY
In addition to analysis and screening services, we plan to sell software and provide SaaS in the future.
Please contact us to discuss how we can customize a solution to meet your needs, including the establishment of a computing environment.
-
Target Analysis
- AI generation and analysis of multiple putative target structures
- Enhancement of low-resolution structural data
READ MORE
-
Ultra Large Scale Virtual Screening
- Construction of ultra-large scale and AI-generated virtual libraries.
- Virtual Screening approach designed to fit customer needs using SBVS or LBVS.
- Low-cost, large-scale Virtual Screening
READ MORE
-
Free Energy Perturbation（FEP）
- Absolute binding free energy calculation
- High-speed quantum chemical calculations
READ MORE
NEWS / BLOG
-
2025.04 23
NEWS
Xeureka begins AI drug discovery research support on constrained peptides with FunPepREAD MORE
-
2025.01 10
BLOG
【Case study】Development of a large-scale virtual screening drug discovery platform (XEDOCK) based on KubernetesREAD MORE
-
2024.12 23
NEWS
Xeureka Held the Second Executive Board Meeting of Tokyo-1READ MORE